Drug Profile
Fentanyl controlled-release - Onxeo
Alternative Names: BA-041; Fentanyl LauriadLatest Information Update: 03 Sep 2014
Price :
$50
*
At a glance
- Originator BioAlliance Pharma
- Developer Onxeo SA
- Class General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Cancer pain
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 03 Sep 2014 Discontinued - Phase-I/II for Cancer pain (In volunteers) in France (Buccal)
- 01 Aug 2014 TopoTarget has merged with BioAlliance Pharma to form Onxeo SA
- 08 Aug 2013 Biomarkers information updated